AUNA trades 47.6% below Wall Street's consensus target of $7.63.
Last 12 months price action with 12-month analyst target path
The base valuation assumes AUNA achieves its forward estimates and maintains a stable P/E multiple of 1.7x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Auna S.A. (AUNA) has a Wall Street consensus price target of $7.63, based on estimates from 1 covering analysts. With the stock currently trading at $5.17, this represents a potential upside of +47.6%. The company has a market capitalization of $383M.
Analyst price targets range from a low of $6.90 to a high of $9.00, representing a 28% spread in expectations. The median target of $7.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, AUNA trades at a trailing P/E of 5.8x and forward P/E of 1.7x. Analysts expect EPS to grow +221.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $0.87, with bear and bull scenarios of $0.55 and $1.15 respectively. Model confidence stands at 61/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
UHSUniversal Health Services, Inc. | $10.1B | $161.26 | $216.00 | +33.9% | Hold | 6.9x | 43 |
THCTenet Healthcare Corporation | $16.8B | $191.20 | $259.50 | +35.7% | Buy | 10.7x | 32 |
CYHCommunity Health Systems, Inc. | $538M | $3.82 | $2.93 | -23.3% | Hold | — | 37 |
HCAHCA Healthcare, Inc. | $93.9B | $423.11 | $504.73 | +19.3% | Buy | 14.0x | 46 |
RDNTRadNet, Inc. | $5.3B | $67.83 | $85.00 | +25.3% | Buy | 131.5x | 11 |
SGRYSurgery Partners, Inc. | $2.2B | $17.17 | $19.33 | +12.6% | Buy | 40.0x | 22 |
AMSFAMERISAFE, Inc. | $663M | $35.45 | $44.50 | +25.5% | Buy | 16.9x | 6 |
ACHCAcadia Healthcare Company, Inc. | $2.9B | $31.92 | $28.33 | -11.2% | Buy | 21.2x | 25 |
SEMSelect Medical Holdings Corporation | $2.0B | $16.51 | $17.75 | +7.5% | Hold | 13.5x | 14 |
ENSGThe Ensign Group, Inc. | $10.0B | $170.87 | $222.33 | +30.1% | Buy | 22.6x | 13 |
Quick answers to the most common questions about buying AUNA stock.
The consensus Wall Street price target for AUNA is $7.63, representing 47.6% upside from the current price of $5.17. With 1 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AUNA has a consensus rating of "Hold" based on 1 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $7.63 implies 47.6% upside from current levels.
With a forward P/E of 1.7149x, AUNA trades at a relatively low valuation. The consensus target of $7.63 implies 47.6% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $9 for AUNA, while the most conservative target is $6.9. The consensus of $7.63 represents the median expectation. Our quantitative valuation model projects a bull case target of $1 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
AUNA is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AUNA stock forecast based on 1 Wall Street analysts shows a consensus price target of $7.63, with estimates ranging from $6.9 (bear case) to $9 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $1, with bear/bull scenarios of $1/$1.
Our quantitative valuation model calculates AUNA's fair value at $1 (base case), with a bear case of $1 and bull case of $1. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 61/100.
AUNA trades at a forward P/E ratio of 1.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 5.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on AUNA, with a "Hold" consensus rating and $7.63 price target (47.6% upside). 0 of 1 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AUNA analyst price targets range from $6.9 to $9, a 28% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $7.63 consensus represents the middle ground. Our model's $1-$1 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.